Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA

被引:264
作者
Yang, JP [1 ]
Huang, L [1 ]
机构
[1] UNIV PITTSBURGH,SCH MED,DEPT PHARMACOL,LAB DRUG TARGETING,PITTSBURGH,PA 15261
关键词
liposomes; cationic liposome; lipofection; serum inhibitory; charge ratio; murine melanoma;
D O I
10.1038/sj.gt.3300485
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Since cationic liposome was first developed as a lipofection reagent, a drawback has been noted in that the efficiency of lipofection decreases dramatically after addition of serum to the lipofection medium. This drawback hampers the application of cationic liposome for systematic delivery of genes. In the present studies, we found that the effect of serum on DC-chol liposome-mediated lipofection is dependent on the charge ratio of liposome to DNA. Serum inhibited lipofection activity of the lipoplex at low charge ratios, whereas it enhanced the lipofection activity at high charge ratios. This phenomenon was observed using DOTAP/DOPE but not lipofectamine. Measurement of cellular association of DNA showed that serum could reduce the binding of lipoplex to cells at all tested charge ratios, ie 0=10.6. Removal of negatively charged proteins from serum by DEAE-Sephacel column abolished the inhibitory effect of serum on lipofection. The fraction contained only negatively charged serum proteins which strongly inhibited lipofection at low charge ratios but not at higher charge ratios. Furthermore, preincubation of serum with positively charged polylysine, which neutralized negatively charged serum proteins, eliminated the inhibitory cationic liposome by serum is due to negatively charged serum proteins and it can be overcome by increasing charge ratio of cationic liposome-DNA lipoplexes or by neutralizing the serum with polylysine.
引用
收藏
页码:950 / 960
页数:11
相关论文
共 37 条
  • [1] BONIFACINO JS, 1991, CURRENT PROTOCOLS MO
  • [2] LIPOFECTION DOES NOT REQUIRE THE REMOVAL OF SERUM
    BRUNETTE, E
    STRIBLING, R
    DEBS, R
    [J]. NUCLEIC ACIDS RESEARCH, 1992, 20 (05) : 1151 - 1151
  • [3] LIPOSOME-MEDIATED CFTR GENE-TRANSFER TO THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC-FIBROSIS
    CAPLEN, NJ
    ALTON, EWFW
    MIDDLETON, PG
    DORIN, JR
    STEVENSON, BJ
    GAO, X
    DURHAM, SR
    JEFFERY, PK
    HODSON, ME
    COUTELLE, C
    HUANG, L
    PORTEOUS, DJ
    WILLIAMSON, R
    GEDDES, DM
    [J]. NATURE MEDICINE, 1995, 1 (01) : 39 - 46
  • [4] Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin
    Cheng, PW
    [J]. HUMAN GENE THERAPY, 1996, 7 (03) : 275 - 282
  • [5] SEPARATION OF LARGE UNILAMELLAR LIPOSOMES FROM BLOOD COMPONENTS BY A SPIN COLUMN PROCEDURE - TOWARDS IDENTIFYING PLASMA-PROTEINS WHICH MEDIATE LIPOSOME CLEARANCE INVIVO
    CHONN, A
    SEMPLE, SC
    CULLIS, PR
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1070 (01) : 215 - 222
  • [6] FIREFLY LUCIFERASE GENE - STRUCTURE AND EXPRESSION IN MAMMALIAN-CELLS
    DEWET, JR
    WOOD, KV
    DELUCA, M
    HELINSKI, DR
    SUBRAMANI, S
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (02) : 725 - 737
  • [7] ENDOCYTOSIS IN MOUSE BLASTOCYSTS - CHARACTERIZATION AND QUANTIFICATION OF THE FLUID-PHASE COMPONENT
    DUNGLISON, GF
    KAYE, PL
    [J]. MOLECULAR REPRODUCTION AND DEVELOPMENT, 1995, 41 (02) : 225 - 231
  • [8] Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer
    Egilmez, NK
    Iwanuma, Y
    Bankert, RB
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 221 (01) : 169 - 173
  • [9] LIPOFECTION - A HIGHLY EFFICIENT, LIPID-MEDIATED DNA-TRANSFECTION PROCEDURE
    FELGNER, PL
    GADEK, TR
    HOLM, M
    ROMAN, R
    CHAN, HW
    WENZ, M
    NORTHROP, JP
    RINGOLD, GM
    DANIELSEN, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7413 - 7417
  • [10] VACCINATION WITH CYTOTOXIC T-LYMPHOCYTE EPITOPE-CONTAINING PEPTIDE PROTECTS AGAINST A TUMOR-INDUCED BY HUMAN PAPILLOMAVIRUS TYPE-16-TRANSFORMED CELLS
    FELTKAMP, MCW
    SMITS, HL
    VIERBOOM, MPM
    MINNAAR, RP
    DEJONGH, BM
    DRIJFHOUT, JW
    TERSCHEGGET, J
    MELIEF, CJM
    KAST, WM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) : 2242 - 2249